La presentazione è in caricamento. Aspetta per favore

La presentazione è in caricamento. Aspetta per favore

MINI01.01: Whole Body and Intracranial Efficacy of Ceritinib in ALK-inhibitor Naïve Patients with ALK+ NSCLC and Brain Metastases: Results of ASCEND 1.

Presentazioni simili


Presentazione sul tema: "MINI01.01: Whole Body and Intracranial Efficacy of Ceritinib in ALK-inhibitor Naïve Patients with ALK+ NSCLC and Brain Metastases: Results of ASCEND 1."— Transcript della presentazione:

1 MINI01.01: Whole Body and Intracranial Efficacy of Ceritinib in ALK-inhibitor Naïve Patients with ALK+ NSCLC and Brain Metastases: Results of ASCEND 1 and 3  Alice T. Shaw, David R. Spigel, Daniel S.-W. Tan, Dong-Wan Kim, Ranee Mehra, Sergey Orlov, Keunchil Park, Chong-Jen Yu, Tony Mok, Makoto Nishio, Giorgio Scagliotti, Santosh Sutradhar, Dajana Cesic, Enriqueta Felip  Journal of Thoracic Oncology  Volume 11, Issue 11, (November 2016) DOI: /j.jtho Copyright © Terms and Conditions

2 Journal of Thoracic Oncology 2016 11, DOI: (10. 1016/j. jtho. 2016. 09
Copyright © Terms and Conditions


Scaricare ppt "MINI01.01: Whole Body and Intracranial Efficacy of Ceritinib in ALK-inhibitor Naïve Patients with ALK+ NSCLC and Brain Metastases: Results of ASCEND 1."

Presentazioni simili


Annunci Google